Hereditary cancer risk assessment and genetic testing in the community urology practice setting.
Saved in:
| Title: | Hereditary cancer risk assessment and genetic testing in the community urology practice setting. |
|---|---|
| Authors: | Shore ND; Carolina Urologic Research Center/GenesisCare, Myrtle Beach, South Carolina, USA., Lenz L; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Cogan ES; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Iliev D; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Spencer L; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Flake DD 2nd; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Meek S; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Davis T; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Copeland K; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Finch R; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Schiff W; Urology Associates of Central California, Fresno, California, USA., Korman H; Comprehensive Urology, Royal Oak, Michigan, USA., Rao M; Urologic Specialists of Northwest Indiana, Merrillville, Indiana, USA., Belkoff L; MidLantic Urology, Bala Cynwyd, Pennsylvania, USA., Jalkut M; Associated Urologists of North Carolina, Raleigh, North Carolina, USA., Mariados N; Associated Medical Professionals, Syracuse, New York, USA., D'Anna R; Arkansas Urology, Little Rock, Arkansas, USA., Mehlhaff B; Oregon Urology Institute, Springfield, Oregon, USA., Slavin TP; Myriad Genetics, Inc., Salt Lake City, Utah, USA., Cohen TD; Myriad Genetics, Inc., Salt Lake City, Utah, USA. |
| Source: | The Prostate [Prostate] 2022 May; Vol. 82 (7), pp. 850-857. Date of Electronic Publication: 2022 Mar 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
